about
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in HumansDegeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseVasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and InterventionsEnabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesInsulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's diseaseBrain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogsAberrant insulin signaling in Alzheimer's disease: current knowledgeDietary Reversal Ameliorates Short- and Long-Term Memory Deficits Induced by High-fat Diet Early in LifePeptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brainInsulin in the nervous system and the mind: Functions in metabolism, memory, and moodDiabetes Mellitus and Blood-Brain Barrier Dysfunction: An OverviewPostsynaptic distribution of IRSp53 in spiny excitatory and inhibitory neuronsBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialLong-term high-fat diet induces hippocampal microvascular insulin resistance and cognitive dysfunction.NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.Dicholine succinate, the neuronal insulin sensitizer, normalizes behavior, REM sleep, hippocampal pGSK3 beta and mRNAs of NMDA receptor subunits in mouse models of depression.Diabetes mellitus and disturbances in brain connectivity: a bidirectional relationship?Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.Diabetes and Cognitive Impairment.The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains.Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hormones of energy balance in a TCDD-sensitive and a TCDD-resistant rat strain.Therapeutic effect of vagus nerve stimulation on depressive-like behavior, hyperglycemia and insulin receptor expression in Zucker fatty ratsIntranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative DiseasesPTP1B inhibition suggests a therapeutic strategy for Rett syndromeHypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue.Nano-enabled delivery of diverse payloads across complex biological barriers.Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsRelationship between Insulin-Resistance Processing Speed and Specific Executive Function Profiles in Neurologically Intact Older Adults.Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits.Pharmacologic manipulation of lysosomal enzyme transport across the blood-brain barrier.Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study.Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.Evaluating Crossbred Red Rice Variants for Postprandial Glucometabolic Responses: A Comparison with Commercial Varieties.Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's diseaseBlood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.MeCP2 co-ordinates liver lipid metabolism with the NCoR1/HDAC3 corepressor complex.The influence of glycemic index on cognitive functioning: a systematic review of the evidence.
P2860
Q26739671-E9995D91-1BA0-44A8-BD5D-6DA50B4A538AQ26750370-59C487AF-E560-449C-BB53-4F81C49E4AFEQ26781557-27218696-6E5C-48FF-B211-B230E9EF798BQ26850868-0A926048-F056-4BDB-98B1-7ADA35CBA299Q26866392-960602DE-B59D-44E0-93FB-BB07F92D86C4Q27012801-9C15C385-2CAA-41F4-9505-755154C9F921Q27024222-3ED6DA6B-3A60-4DF3-9883-1A25951CA7A9Q27321064-41E4A5C7-0F00-4E54-B391-5921AEBA2605Q27331875-B2218477-847C-4AF0-B249-4A8863D11544Q28079442-4F90DC90-85E3-4C1D-8C25-6BB84D0AB325Q28386522-668A4B58-5AD5-4A93-BDB3-F08A857ED70EQ28583499-BD910D94-DB69-4F35-BE6D-5EEA2E30FDEBQ29994589-B315E64C-B579-44F2-A07E-6C4F05A98103Q30275335-400237EE-714F-4B88-8B6A-B99C68A5ED02Q30352890-880A294F-00D0-4E79-B136-51AE33388999Q30621713-5D5FFCB5-F896-47C9-95C8-1903AD9D90C8Q30833828-3F9DE922-E139-4603-A209-8CB1204C0D56Q31109560-2D5B2370-A087-4F42-B220-EC3E07E9F1B9Q31119662-69A474ED-9320-4EDD-B2E5-1A1AFF4BBC70Q33600053-05BEEE76-B791-4728-A5F3-B7647B5CDE1DQ33628048-1FB532B5-C5A8-436E-AC2D-CCC14812E242Q34044114-E3AA1DB3-3F1B-48E5-8E3D-27CC4136639CQ34158496-D525F690-FB10-4B67-9BF5-11DAF41EEF90Q34445871-02BDB3E3-E385-4C41-9608-793E594C4B70Q35768362-F94A7FD9-4C9A-4FA2-9EB4-FB46802BFC31Q36040491-3FA8C15C-3C18-47DC-A8B0-4032FCF2912FQ36106687-81E18F3B-5203-49BB-A287-01B25210F3C5Q36307467-4BB26288-38E9-41A9-AEC2-8EF1EE5069FCQ36578704-E6C05E05-89E6-48D0-B099-16FB09FF8946Q36611401-654150C7-6D84-49AB-8CCB-C559D032B1D6Q36651084-41D9FF0E-B83F-408D-8C74-339E3E50875FQ36692494-DE55F978-1189-4F3F-A43D-ACF783A745BDQ36766235-AFA40CA2-FC3D-4012-808F-BF8AAA9908FFQ36883430-FB1FC1C2-3F3F-459D-8AA4-FCAD1B79BE9CQ36941882-CB294204-A3E1-4880-A2A2-EFE9C3D05E1CQ37158071-FC7EB91B-B788-410A-A4C9-0143B99B5874Q37208538-686F386C-3D96-40F1-A1C9-84F92A370E3AQ37216153-887A189B-973E-48E2-953B-26C4B200DC0CQ37530120-9511F5C1-F9FE-48F4-AC30-EEE4B669A5ABQ37633823-CCD1967C-0140-4575-8D86-CFE434294DB2
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Insulin in the brain: there and back again
@ast
Insulin in the brain: there and back again
@en
Insulin in the brain: there and back again
@nl
type
label
Insulin in the brain: there and back again
@ast
Insulin in the brain: there and back again
@en
Insulin in the brain: there and back again
@nl
prefLabel
Insulin in the brain: there and back again
@ast
Insulin in the brain: there and back again
@en
Insulin in the brain: there and back again
@nl
P2093
P2860
P3181
P1476
Insulin in the brain: there and back again
@en
P2093
Joshua B. Owen
Michelle A. Erickson
William A. Banks
P2860
P3181
P356
10.1016/J.PHARMTHERA.2012.07.006
P407
P577
2012-10-01T00:00:00Z